Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 31% In A Month

Group 1 - Guardant Health stock is attempting to break out of a cup base pattern, with a current price of $69.50, showing a 1% increase and a 37% rise over the past month [1][2] - The stock has a buy point at $66.57, with a composite rating of 75 out of 99 and an industry group ranking of 38 out of 197 [1] - The company specializes in blood tests for colon cancer screening, indicating its position as a leader in this niche market [1] Group 2 - The S&P 500's Walmart is in a buy zone, while Guardant Health is highlighted among stocks in focus due to its recent performance [4] - Guardant Health has received a relative strength rating upgrade, achieving a 92 RS rating, indicating strong market leadership [4] - The stock has experienced volatility, recently tumbling after a significant month-long run of 67% [4]